Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fresia Pareja

Showing results (11-20 of 131) with videos related to

Pageof 14
Sort By:
NPJ Breast Cancer|January 28, 2025
Biological correlates associated with high-risk breast cancer patients identified using a computational methodJung Hun Oh, Fresia Pareja, Rena Elkin, et al.
Human Pathology|June 11, 2022
Expression of novel neuroendocrine markers in breast carcinomas: a study of INSM1, ASCL1, and POU2F3Elaine Zhong, Fresia Pareja, Matthew G Hanna, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2025
Frank Invasion in Tall Cell Carcinoma With Reversed Polarity of the Breast: Report of Two CasesRachel Han, Fresia Pareja, Dara S Ross, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 2025
Human Epidermal Growth Factor Receptor 2 (HER2)-Ultralow Breast Cancer: Incidence, Clinicopathologic Features, and Need for Refined Scoring SystemDoaa Morrar, Edi Brogi, Christopher J Schwartz, et al.
NPJ Breast Cancer|July 20, 2017
Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variantsFresia Pareja, Felipe C Geyer, Caterina Marchiò, et al.
Journal of the American Society of Cytopathology|May 23, 2017
Cytologic assessment of estrogen receptor, progesterone receptor, and HER2 status in metastatic breast carcinomaFresia Pareja, Melissa P Murray, Ryan Des Jean, et al.
Breast Cancer Research and Treatment|March 24, 2026
Rb expression in metastatic ER-positive breast cancer: implications for precision oncologyDoaa Morrar, Dara Ross, Pedram Razavi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 15, 2025
Lung Carcinoma Metastatic to Breast: A Comprehensive Analysis of Clinical Presentation, Morphologic and Molecular Features, with Emphasis on Diagnostic PitfallsAtif Ali Hashmi, Theodore Vougiouklakis, Andrea Gazzo, et al.
Histopathology|June 3, 2026
Landscape of genetic alterations affecting cancer genes in primary and advanced malignant phyllodes tumoursSelma Yeni Yildirim, Pier Selenica, Andrea Gazzo, et al.
Frontiers in Oncology|April 18, 2025
Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterizationDaniela A Ferraro, Bettina Bisig, David C Rotzinger, et al.
Pageof 14

Showing results (11-20 of 131) with videos related to

Sort By:
Pageof 14
NPJ Breast Cancer|January 28, 2025
Biological correlates associated with high-risk breast cancer patients identified using a computational methodJung Hun Oh, Fresia Pareja, Rena Elkin, et al.
Human Pathology|June 11, 2022
Expression of novel neuroendocrine markers in breast carcinomas: a study of INSM1, ASCL1, and POU2F3Elaine Zhong, Fresia Pareja, Matthew G Hanna, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 19, 2025
Frank Invasion in Tall Cell Carcinoma With Reversed Polarity of the Breast: Report of Two CasesRachel Han, Fresia Pareja, Dara S Ross, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 1, 2025
Human Epidermal Growth Factor Receptor 2 (HER2)-Ultralow Breast Cancer: Incidence, Clinicopathologic Features, and Need for Refined Scoring SystemDoaa Morrar, Edi Brogi, Christopher J Schwartz, et al.
NPJ Breast Cancer|July 20, 2017
Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variantsFresia Pareja, Felipe C Geyer, Caterina Marchiò, et al.
Journal of the American Society of Cytopathology|May 23, 2017
Cytologic assessment of estrogen receptor, progesterone receptor, and HER2 status in metastatic breast carcinomaFresia Pareja, Melissa P Murray, Ryan Des Jean, et al.
Breast Cancer Research and Treatment|March 24, 2026
Rb expression in metastatic ER-positive breast cancer: implications for precision oncologyDoaa Morrar, Dara Ross, Pedram Razavi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 15, 2025
Lung Carcinoma Metastatic to Breast: A Comprehensive Analysis of Clinical Presentation, Morphologic and Molecular Features, with Emphasis on Diagnostic PitfallsAtif Ali Hashmi, Theodore Vougiouklakis, Andrea Gazzo, et al.
Histopathology|June 3, 2026
Landscape of genetic alterations affecting cancer genes in primary and advanced malignant phyllodes tumoursSelma Yeni Yildirim, Pier Selenica, Andrea Gazzo, et al.
Frontiers in Oncology|April 18, 2025
Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterizationDaniela A Ferraro, Bettina Bisig, David C Rotzinger, et al.
Pageof 14